![Mark G. Osterman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark G.
Osterman — Joined Discovery in June 2004 as Senior Vice President, Sales and Marketing.
Mr. Osterman brings with him over 16 years of industry experience with leading pharmaceutical companies.
Prior to Discovery, Mr. Osterman was at Johnson & Johnson where he served in a variety of positions including Vice President at Johnson & Johnson Development Corporation and Executive Director - Global Biologics Strategic Marketing Group at Centocor, Inc., where he oversaw and built marketing functions for the cardio-pulmonary, metabolism and infectious disease therapeutic areas.
While at Centocor, Mr. Osterman lead the commercial due diligence team in Johnson & Johnson’s acquisition of Scios Inc. Previously, Mr. Osterman was at GlaxoSmithKline, his most senior position being Director, Pulmonary Portfolio - Global Marketing Group where he was involved with the successful launch of several respiratory products including Serevent® for the COPD (Chronic Obstructive Pulmonary Disease) and pediatric indications.
Earlier in his career, Osterman was a product manager, respiratory medical liaison and sales representative.
Mr. Osterman has dual B.A. degrees in Economics and Business Management from North Carolina State University.
Anciens postes connus de Mark G. Osterman
| Sociétés | Poste | Fin |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Sales & Marketing | 28/04/2006 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Corporate Officer/Principal | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Directeur/Membre du Conseil | - |
Formation de Mark G. Osterman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
